BNP Paribas Financial Markets
DERM icon

BNP Paribas Financial Markets’s Journey Medical DERM Stock Holding History

BNP Paribas Financial Markets’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
47,411
+42,761
+920% +$244K ﹤0.01% 3974
2026
Q1 		$21.8K Sell
4,650
-23,169
-83% -$180K ﹤0.01% 5062
2025
Q4 		$214K Buy
27,819
+25,131
+935% +$197K ﹤0.01% 4027
2025
Q3 		$19.1K Buy
2,688
+1,225
+84% +$8.88K ﹤0.01% 4911
2025
Q2 		$10.5K Buy
+1,463
New +$10.1K ﹤0.01% 4830

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

BNP Paribas Financial Markets's DERM Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Journey Medical (DERM) stake by 920% in Q2 2026, buying an estimated $244K and bringing the position to 47,411 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #3974.

BNP Paribas Financial Markets first reported a position in DERM in Q2 2025 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • BNP Paribas Financial Markets held 47,411 shares of Journey Medical worth $336K as of Q2 2026.
  • BNP Paribas Financial Markets bought 42,761 Journey Medical shares in Q2 2026, an estimated $244K.
  • Journey Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3974 holding.
  • BNP Paribas Financial Markets first reported a position in Journey Medical in Q2 2025 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.